Μ1. Design, development and pharmacological evaluation of pharmacomolecule action - preformulation studies

Purpose/Objectives of the Course

In the context of the course, the following topics are developed: Study of preformulation-formulation in modern pharmaceutical forms. Quantitative Structure Activity Relationships (QSAR), Physicochemical Properties, Chemometrics, Simulation, Fundamentals and Examples of 2D and 3D-QSAR relationships for various molecular targets. ADMET models. Simulation models. Solid phase selection – Polymorphism control.

 Physico-mechanical properties of powders (size, shape, flow, compressibility). Computational simulation of the solid state (prediction, crystal polymorphism, mechanical properties estimation, crystal morphology prediction). Design and development of products: Selection of excipients and factors that determine them in the production of solid pharmaceutical products (Tablets). Evidence of anticancer drug development. Pharmacological and pharmacogenomic approach. Design, Production and Quality Control of Radiopharmaceutical (pre) Formulations. Development of production methods and quality control of radiopharmaceutical preparations and preparations.

Coordinator

Teachers

Course Organization

ECTS: 8

Lectures: 12
Laboratory Exercises: 1
PC application: 1

Workload

200 – 240 hours
Lectures/Workshops: 70 hours
Personal effort: 130 hours

Course Lectures

Week

Faculty

Teaching method 

Description of teaching unit

1

Hatzipavlou-Litina Dimitra

Prof. of Pharmaceutical Chemistry, AUTH

Theory

Quantitative structure-activity relationships (QSAR), Physicochemical properties, Chemometrics, Simulation, Fundamentals, Examples of 2D and 3D-QSAR relationships for various molecular targets

2

Hatzipavlou-Litina Dimitra

Prof. of Pharmaceutical Chemistry, AUTH

Theory

ADMET Models and Hybridization Theory,

3

Hatzipavlou-Litina Dimitra

Prof. of Pharmaceutical Chemistry, AUTH

P/C

ADMET models: The Multi-target principle, ligands design

4

Nikolaou Ioannis, Asst.Prof. of Pharmaceutical Chemistry, AUTH

Theory

DESIGNING DRUGS TO AVOID TOXICITY

5

Barbalexis Panagiotis

Asst. Prof. of Pharm. Technology, AUTH

Theory

Physico-mechanical properties of powder (size, shape, flow, compressibility)

6

Kahrimanis Kyriakos.

Prof. of Pharm. Technology, AUTH

Theory

Solid phase selection – polymorphism control

7

Kahrimanis Kyriakos.

Prof. of Pharm. Technology, AUTH

Theory

Theory

 

Computational simulation of the solid state (prediction, crystal polymorphism, mechanical property estimation, crystal morphology prediction)

8

Vizirianakis Ioannis, Asst. Professor of Pharmacology AUTH

Theory

Anticancer drug development data. Pharmacological and pharmacogenomic approach.

9

Papagiannopoulou Dionysia

Asst. Prof. at Radiopharmaceuticals, AUTH

Theory

Design, Production and Quality Control of Radiopharmaceutical (pre) Formulations.

10

Konstantinos Kagadis Ph.D. General Manager CBL Patras S.A.

Theory

Lyophilization part I

11

Konstantinos Kagadis Ph.D. General Manager CBL Patras S.A. 

Theory

Lyophilization part II

12

Karavas Evangelos

PhD. President PHARMATEN SA, Vice President of Research & Industrial Operations and Director

Theory

Study of pre-formulation/formulation in modern pharmaceutical preparations

13

George Soras

Phd, Rnd and RA Manager

Theory

Design and development of products: Selection of excipients and factors that determine them in the production of solid pharmaceutical products (Tablets).

14

Exams Theory

Examination of the course

Final exam

0%

Course Essays

0%

Related Bibliography

Handbook of Personalized Medicine – Advances in Nanotechnology, Drug Delivery and Therapeutics

Editor: Ioannis S. Vizirianakis

ISBN: 9789601224831

Link

Scroll to Top